Modelling and Analysis of the Complement System Signalling Pathways: Roles of C3, C5a and Pro-inflammatory Cytokines in SARS-CoV-2 Infection

Overview

Journal PeerJ

Specialties Biology
Environmental Health
General Medicine

Date 2023 Sep 25

PMID 37744234

Authors

Didar Murad

Rehan Zafar Paracha

Muhammad Tariq Saeed

Jamil Ahmad

Ammar Mushtaq

Maleeha Humayun

Affiliations

Soon will be listed here.

Abstract

The complement system is an essential part of innate immunity. It is activated by invading pathogens causing inflammation, opsonization, and lysis complement anaphylatoxins, complement opsonin's and membrane attack complex (MAC), respectively. However, in SARS-CoV-2 infection overactivation of complement system is causing cytokine storm leading to multiple organs damage. In this study, the René Thomas kinetic logic approach was used for the development of biological regulatory network (BRN) to model SARS-CoV-2 mediated complement system signalling pathways. Betweenness centrality analysis in cytoscape was adopted for the selection of the most biologically plausible states in state graph. Among the model results, in strongly connected components (SCCs) pro-inflammatory cytokines (PICyts) oscillatory behaviour between recurrent generation and downregulation was found as the main feature of SARS-CoV-2 infection. Diversion of trajectories from the SCCs leading toward hyper-inflammatory response was found in agreement with studies that overactive innate immunity response caused PICyts storm during SARS-CoV-2 infection. The complex of negative regulators FI, CR1 and DAF in the inhibition of complement peptide (C5a) and PICyts was found desirable to increase immune responses. In modelling role of MAC and PICyts in lowering of SARS-CoV-2 titre was found coherent with experimental studies. Intervention in upregulation of C5a and PICyts by C3 was found helpful in back-and-forth variation of signalling pattern linked with the levels of PICyts. Moreover, intervention in upregulation of PICyts by C5a was found productive in downregulation of all activating factors in the normal SCCs. However, the computational model predictions require experimental studies to be validated by exploring the activation role of C3 and C5a which could change levels of PICyts at various phases of SARS-CoV-2 infection.

Citing Articles

Unravelling the impact of SARS-CoV-2 on hemostatic and complement systems: a systems immunology perspective.

Murad D, Paracha R, Nisar M Front Immunol. 2025; 15:1457324.

PMID: 39885991 PMC: 11781117. DOI: 10.3389/fimmu.2024.1457324.

References

Ng N, Powell C . Targeting the Complement Cascade in the Pathophysiology of COVID-19 Disease. J Clin Med. 2021; 10(10). PMC: 8158769. DOI: 10.3390/jcm10102188. View

Velikova T, Georgiev T . SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis. Rheumatol Int. 2021; 41(3):509-518. PMC: 7846902. DOI: 10.1007/s00296-021-04792-9. View

Aslam B, Ahmad J, Ali A, Paracha R, Tareen S, Niazi U . On the modelling and analysis of the regulatory network of dengue virus pathogenesis and clearance. Comput Biol Chem. 2014; 53PB:277-291. DOI: 10.1016/j.compbiolchem.2014.10.003. View

Dijkstra D, Joeloemsingh J, Bajema I, Trouw L . Complement activation and regulation in rheumatic disease. Semin Immunol. 2019; 45:101339. DOI: 10.1016/j.smim.2019.101339. View

Lubbers R, van Essen M, van Kooten C, Trouw L . Production of complement components by cells of the immune system. Clin Exp Immunol. 2017; 188(2):183-194. PMC: 5383442. DOI: 10.1111/cei.12952. View

Shinjyo N, Kagaya W, Pekna M . Interaction Between the Complement System and Infectious Agents - A Potential Mechanistic Link to Neurodegeneration and Dementia. Front Cell Neurosci. 2021; 15:710390. PMC: 8365172. DOI: 10.3389/fncel.2021.710390. View

Carvelli J, Demaria O, Vely F, Batista L, Chouaki Benmansour N, Fares J . Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis. Nature. 2020; 588(7836):146-150. PMC: 7116884. DOI: 10.1038/s41586-020-2600-6. View

Ren X, Zhou J, Guo J, Hao C, Zheng M, Zhang R . Reinfection in patients with COVID-19: a systematic review. Glob Health Res Policy. 2022; 7(1):12. PMC: 9051013. DOI: 10.1186/s41256-022-00245-3. View

Zewde N, Morikis D . A computational model for the evaluation of complement system regulation under homeostasis, disease, and drug intervention. PLoS One. 2018; 13(6):e0198644. PMC: 5991421. DOI: 10.1371/journal.pone.0198644. View

10.

Zewde N, Hsu R, Morikis D, Palermo G . Systems Biology Modeling of the Complement System Under Immune Susceptible Pathogens. Front Phys. 2022; 9. PMC: 8827490. DOI: 10.3389/fphy.2021.603704. View

11.

Bernot G, Comet J, Richard A, Guespin J . Application of formal methods to biological regulatory networks: extending Thomas' asynchronous logical approach with temporal logic. J Theor Biol. 2004; 229(3):339-47. DOI: 10.1016/j.jtbi.2004.04.003. View

12.

Saadatpour A, Albert R, Reluga T . A REDUCTION METHOD FOR BOOLEAN NETWORK MODELS PROVEN TO CONSERVE ATTRACTORS. SIAM J Appl Dyn Syst. 2020; 12(4):1997-2011. PMC: 7597850. DOI: 10.1137/13090537X. View

13.

Najjar S, Najjar A, Chong D, Pramanik B, Kirsch C, Kuzniecky R . Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation. 2020; 17(1):231. PMC: 7406702. DOI: 10.1186/s12974-020-01896-0. View

14.

Mihalopoulos M, Dogra N, Mohamed N, Badani K, Kyprianou N . COVID-19 and Kidney Disease: Molecular Determinants and Clinical Implications in Renal Cancer. Eur Urol Focus. 2020; 6(5):1086-1096. PMC: 7280142. DOI: 10.1016/j.euf.2020.06.002. View

15.

Saeed M, Ahmad J, Baumbach J, Pauling J, Shafi A, Paracha R . Parameter estimation of qualitative biological regulatory networks on high performance computing hardware. BMC Syst Biol. 2018; 12(1):146. PMC: 6311083. DOI: 10.1186/s12918-018-0670-y. View

16.

Mastaglio S, Ruggeri A, Risitano A, Angelillo P, Yancopoulou D, Mastellos D . The first case of COVID-19 treated with the complement C3 inhibitor AMY-101. Clin Immunol. 2020; 215:108450. PMC: 7189192. DOI: 10.1016/j.clim.2020.108450. View

17.

Detsika M, Lianos E . Regulation of Complement Activation by Heme Oxygenase-1 (HO-1) in Kidney Injury. Antioxidants (Basel). 2021; 10(1). PMC: 7825075. DOI: 10.3390/antiox10010060. View

18.

Noris M, Benigni A, Remuzzi G . The case of complement activation in COVID-19 multiorgan impact. Kidney Int. 2020; 98(2):314-322. PMC: 7246017. DOI: 10.1016/j.kint.2020.05.013. View

19.

Tang B, Bragazzi N, Li Q, Tang S, Xiao Y, Wu J . An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov). Infect Dis Model. 2020; 5:248-255. PMC: 7029158. DOI: 10.1016/j.idm.2020.02.001. View

20.

Zewde N, Gorham Jr R, Dorado A, Morikis D . Quantitative Modeling of the Alternative Pathway of the Complement System. PLoS One. 2016; 11(3):e0152337. PMC: 4816337. DOI: 10.1371/journal.pone.0152337. View